The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B)

Neuropharmacology
Eric JüttlerMarkus Schwaninger

Abstract

Exogenous and endogenous cannabinoids have been shown to have neuroprotective effects in vitro and in vivo. Although many of the pharmacological effects of cannabinoids have been identified, the mechanism of neuroprotection still represents a controversy. Here we demonstrate for the first time protective effects of the synthetic cannabinoid dexanabinol by inhibiting apoptosis in a neuron-like cell line using nuclear staining and FACS analysis and in primary neurons. We provide further evidence of inhibition of nuclear factor-kappakappa B (NF-kappaB) by dexanabinol: Dexanabinol inhibits (1) phosphorylation and degradation of the inhibitor of NF-kappaB IkappaBalpha and translocation of NF-kappaB to the nucleus; dexanabinol reduces (2) the transcriptional activity of NF-kappaB and (3) mRNA accumulation of the NF-kappaB target genes tumor necrosis factor-alpha and interleukin-6 (TNF-alpha and IL-6). Dexanabinol does not bind to cannabinoid (CB) receptors 1 and 2. To investigate the mechanism of action, we employed the non-antioxidant CB1 receptor agonist WIN 55,212-2 and the antioxidant cannabinol, which binds to CB1 receptors only weakly. Both cannabinoids mimicked the effect of dexanabinol on NF-kappaB and apoptosis. This suggest...Continue Reading

References

May 1, 1990·Molecular and Cellular Biology·T A Libermann, D Baltimore
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J J FeigenbaumM Sokolovsky
Aug 1, 1995·Neurological Research·A Biegon, A B Joseph
Sep 5, 1995·European Journal of Pharmacology·N EshharA Biegon
Oct 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·D Burnette-Curley, G A Cabral
Jan 22, 1993·The Journal of Comparative Neurology·L A MatsudaS J Lolait
Jan 1, 1996·Annual Review of Immunology·A S Baldwin
Oct 4, 1996·Cell·P A Baeuerle, D Baltimore
Jan 1, 1997·Pharmacology & Therapeutics·R G Pertwee
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·A J HampsonD Wink
Aug 26, 1998·Drug and Alcohol Dependence·S R Childers, C S Breivogel
Mar 23, 1999·Nature Medicine·H Schneider, C Coutelle
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·A ZimmerT I Bonner
Feb 11, 2000·Annals of the New York Academy of Sciences·M G FilbertG P Ballough
May 29, 2000·The Journal of Biological Chemistry·C S Simpson, B J Morris
Jun 10, 2000·European Journal of Biochemistry·B KaltschmidtM L Schmitz
Jul 6, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·V Di MarzoJ M Brotchie
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·A M MalfaitM Feldmann
Mar 28, 2001·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·M GuzmánI Galve-Roperh
Aug 15, 2002·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Chang J HuangJean de Vellis
Nov 19, 2002·Biochemical and Biophysical Research Communications·Lin XuXinkang Wang
Jan 25, 2003·Critical Care Medicine·Hülya BayirPatrick M Kochanek
Jul 4, 2003·The EMBO Journal·Makio HayakawaKiyomi Kikugawa

❮ Previous
Next ❯

Citations

Jun 25, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Hong LiAshok Kumar
Feb 8, 2008·Neurosurgical Review·Ramazan DurmazAmselem Shimon
Jul 20, 2013·Journal of Medicinal Chemistry·Sangdon HanRobert M Jones
Jun 22, 2012·Journal of Neuroinflammation·Jürg Gertsch, Sharon Anavi-Goffer
Apr 21, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Daniele De FilippisTeresa Iuvone
Oct 7, 2006·The Journal of Biological Chemistry·Xianrong MaoSteven W Barger
Jul 19, 2005·Expert Opinion on Investigational Drugs·Lara Teare, John Zajicek
Jan 29, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Wen ZhangMarkus Schwaninger
Aug 14, 2013·European Journal of Clinical Investigation·Reza RahimianDmitry Lim
Apr 19, 2015·Molecular Neurodegeneration·Sandeep Vasant More, Dong-Kug Choi
May 30, 2006·Neurochemistry International·Peter K BonfilsFlemming Fryd Johansen
Aug 23, 2007·Chemistry & Biodiversity·Eric Stern, Didier M Lambert
Feb 26, 2019·Journal of Neurochemistry·Niraj Kumar JhaVineet Kumar Goswami
Sep 30, 2014·Expert Review of Neurotherapeutics·G Kenneth GrayEtty N Benveniste
Jun 20, 2019·Frontiers in Pharmacology·Paula Morales, Nadine Jagerovic
Nov 4, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sasidhar MurikinatiMarkus Schwaninger
Feb 8, 2020·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Jyotpal Singh, John Patrick Neary
Sep 10, 2018·The Journal of Thoracic and Cardiovascular Surgery·Jia HuoBin-Xiao Su
Jul 5, 2005·Biochimica Et Biophysica Acta·Barbara KaltschmidtChristian Kaltschmidt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.